Phase Genomics

About:

Phase Genomics develops a biotechnology platform for new discoveries in agriculture, human health, and industrial biology industries.

Website: https://phasegenomics.com/

Twitter/X: phasegenomics

Top Investors: National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bill & Melinda Gates Foundation, Congruent Ventures, Four Cities Capital

Description:

Phase Genomics develops a biotechnology platform for new discoveries in agriculture, human health, and industrial biology industries. The company's mission is to help scientists make breakthrough discoveries by providing the most complete, accurate, detailed genomes and metagenomes available from any technology.

Total Funding Amount:

$16.8M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Seattle, Washington, United States

Founded Date:

2015-01-01

Contact Email:

info(AT)phasegenomics.com

Founders:

Ivan Liachko, Jay Shendure, Maitreya Dunham, Shawn Sullivan

Number of Employees:

11-50

Last Funding Date:

2024-03-04

IPO Status:

Private

Industries:

© 2025 bioDAO.ai